Workshop focused on strengthening sterile processing standards, infection prevention, and CSSD best practices in healthcare settings
The lens received U.S. Food and Drug Administration (FDA) market authorization via the De Novo pathway in late 2025
The centre will leverage AI-enabled tools to support research and diagnostics for complex eye–brain disorders
VESCOP, ENTOD Pharmaceuticals, and APTI-MSB host the event to bridge lab-to-clinic gap in eye care
Targets high-growth eye care expansion push
Developed for today’s fast-paced, visually demanding lifestyles, the lenses are built on ZEISS NeurOptix technology
The move represents a significant milestone in Lupin’s strategy to expand its specialty care portfolio and strengthen its presence in Europe
At the center of the collapse is opposition from the Federal Trade Commission
Nearly 12 million people are estimated to be living with glaucoma, making the country one of the worst affected globally
The Hydrus Microstent stands out as the first and only MIGS device backed by five-year clinical outcomes
Subscribe To Our Newsletter & Stay Updated
